Clinical Trials
3 trialsNCT02824042 2020-07-31
Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole
Bayer
Phase 1 Completed
NCT02368951 2017-07-12
Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express Fibroblast Growth Factor Receptor 2 (FGFR2)
Bayer
Phase 1 Terminated
NCT02457351 2016-05-23
Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) Study
Bayer
Phase 1 Completed